82 results on '"Zemlickova, H"'
Search Results
2. Short Report: Carriage of Methicillin-Resistant Staphylococcus aureus in Veterinary Personnel
- Author
-
Žemličková, H., Fridrichová, M., Tyllová, K., Jakubů, V., and Machová, I.
- Published
- 2009
- Full Text
- View/download PDF
3. Defining the scope of the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet): a bottom-up and One Health approach
- Author
-
Mader, R., Demay, C., Jouvin-Marche, E., Ploy, M. -C., Barraud, O., Bernard, S., Lacotte, Y., Pulcini, C., Weinbach, J., Berling, C., Bouqueau, M., Hlava, A., Habl, C., Kernstock, E., Strauss, R., Muchl, R., Buhmann, V., Versporten, A., Ingenbleek, A., Vandael, E., Haelterman, G., De Raedt, L., Hunjak, B., Raickovic, B., Mackova, B., Niklova, E., Zemlickova, H., Hrivnakova, L., Jindrak, V., Kristensen, B., Lyndrup, M., Skovgaard, S., Wolf Sonksen, U., Aasmae, B., Ruut, J., Linnik, L., Sadikova, O., Martin, P., Zanuzdana, A., Kizilkaya-Guneser, G., Oezcelik, N., Eckmanns, T., Lambrou, A., Kontopidou, F., Papadaki, M., Tsana, M., Maroulis, N., Vatopoulos, A., Papadogiannakis, E., Kontarini, M., Gikas, A., Magkanaraki, A., Cozza, A., Martinelli, D., Fortunato, F., Prato, R., Marella, A. M., Pantosti, A., Prestinaci, F., Busani, L., Pezzoti, P., Creti, R., Martoccia, R. M., Brusaferro, S., Vilde, A., Jakovela, A., Langusa, E., Grudule, L., Grinsteine, M., Dumpis, U., Dambrauskiene, A., Vitkauskiene, A., Tirvaite, D., Cemnalianskis, L., Kazenaite, E., Lozoraitiene, I., Adomaitiene, R., Ambrazaitiene, R., Kiveryte, S., Maciulaityte, A., Kuklyte, J., Petrene, J., Valinteliene, R., Kanapeckiene, V., Razmiene, A., Kairiene, B., Aleksiene, G., Valinciute, G., Petraitis, R., Elsemulder, A., Nakched, A., Claessen, J., Gui, L., Kort, M. D., Peran, R., Van Leeuwen, A., Smeets, E., Mennen, M., Spruijt, P., Westerhof, R., Skulberg, A., Bakka, E. Ro., Miard, K., Henricsen, S. Ho., Pellerud, A., Kallberg, C., Ardal, C., Eriksen, H. -M., Kranstad, K., Molvik, M., Kacelnik, O., Sollund, P., Samuelsen, R., Bakke, T., Urdahl, A. M., Norstrom, M., Olczak-Pienkowska, A., Skoczynska, A., Zabicka, D., Bysiek, J., Rekawek, J., Lebre, A., Falcao, E., Scripcaru, G., Neves, I., Gomes, S., Pereira, N., Malutan, A. M., Iuhas, C., Szakacs, L., Kissiedou-Bob, M., Ciortea, R., Grilc, E., Klavs, I., Turk, K., Subelj, M., Vrdelja, M., Serdt, M., Jemec, N., Glavan, U., Simonovic, Z., Tamayo, A. N., Lopez Navas, A., Munoz Madero, C., Alonso Lebrero, J. L., Alonso Irujo, L., Santacreu Garcia, M., Crespo Robledo, P., Oliva, G., Massanes, M., Oliver Palomo, A., Garcia Pineda, A., Ferragut, E., Rojo, E., Castano, E., Perianez, L., Torres Cantero, A. M., Jimenez Guillen, C., Hukelova, H., Alcaraz, M., Carlos, M. A., Lopez Acuna, M. D. P., Gil Setas, A., Ibarrola Segura, A., Ezpeleta, C., Gahigiro Merino, C., Portillo Bordonabe, M. E., Fragoso, M., Beristain Rementeria, X., Penalva, G., Cisneros, J. M., Estevez, M., Monteau, S., Del Rio, L., Gonzalez De Suso, M. J., Gallego Berciano, P., Aranguren Oyarzabal, A., Alioto, D., Izquierdo Palomares, J. M., Calvo Alcantara, M. J., Gonzalez Perez, R., Havarria, T., Hulth, A., Carlin, K., Edman, L., Grape, M., Aspevall, O., Haggar, A., Lindal, E., Burgos, A., Ottoson, J., Ostman, M., Egervarn, M., Nordenfelt, A., Bengtsson, B., Soderman, I., Bjers, A., Jonsson, J. -I., Starborg, M., Laine, M., Fagerstedt, P., Metcalfe, A., Soder, J., Lytsy, B., Madec, J. Y., Collineau, L., Berger-Carbonne, A., Colomb-Cotinat, M., Bourely, C., Amat, J. -P., Broens, E. M., Callens, B., Crespo-Robledo, P., Damborg, P., Filippitzi, M. -E., Fitzgerald, W., Gronthal, T., Haenni, M., Heuvelink, A., Van Hout, J., Kaspar, H., Pedersen, K., Pokludova, L., Dal Pozzo, F., Slowey, R., Zafeiridis, C., Madec, J. -Y., and Departments of Faculty of Veterinary Medicine
- Subjects
Microbiology (medical) ,Veterinary medicine ,Staphylococcus pseudintermedius ,040301 veterinary sciences ,Swine ,Drug Resistance ,413 Veterinary science ,0403 veterinary science ,Animals ,Anti-Bacterial Agents ,Bacteria ,Cats ,Cattle ,Chickens ,Dogs ,Drug Resistance, Bacterial ,Female ,One Health ,03 medical and health sciences ,Antibiotic resistance ,Antimicrobial stewardship ,Medicine ,Pharmacology (medical) ,2. Zero hunger ,Streptococcus uberis ,Pharmacology ,0303 health sciences ,biology ,030306 microbiology ,business.industry ,Bacterial ,04 agricultural and veterinary sciences ,biology.organism_classification ,Antimicrobial ,Food safety ,3. Good health ,Infectious Diseases ,business ,Streptococcus dysgalactiae - Abstract
BackgroundBuilding the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet) was proposed to strengthen the European One Health antimicrobial resistance (AMR) surveillance approach.ObjectivesThe objectives were to (i) define the combinations of animal species, production types, age categories, bacterial species, specimens and antimicrobials to be monitored in EARS-Vet and to (ii) determine antimicrobial test panels able to cover most combinations.MethodsThe EARS-Vet scope was defined by consensus between 26 European experts. Decisions were guided by a survey of the combinations that are relevant and feasible to monitor in diseased animals in 13 European countries (bottom-up approach). Experts also considered the One Health approach and the need for EARS-Vet to complement existing European AMR monitoring systems coordinated by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA).ResultsEARS-Vet would monitor AMR in six animal species (cattle, swine, chicken (broiler and laying hen), turkey, cat and dog), for 11 bacterial species (Escherichia coli, Klebsiella pneumoniae, Mannheimia haemolytica, Pasteurella multocida, Actinobacillus pleuropneumoniae, Staphylococcus aureus, Staphylococcus pseudintermedius, Staphylococcus hyicus, Streptococcus uberis, Streptococcus dysgalactiae and Streptococcus suis). Relevant antimicrobials for their treatment were selected (e.g. tetracyclines) and complemented with antimicrobials of more specific public health interest (e.g. carbapenems). Three test panels of antimicrobials were proposed covering most EARS-Vet combinations of relevance for veterinary antimicrobial stewardship.ConclusionsWith this scope, EARS-Vet would enable to better address animal health in the strategy to mitigate AMR and better understand the multi-sectoral AMR epidemiology in Europe.
- Published
- 2022
- Full Text
- View/download PDF
4. Dissemination of a capsular and antibiotype variant of the England14-9 pneumococcal clone in the Czech Republic
- Author
-
Žemličková, H., Jakubů, V., and Urbášková, P.
- Published
- 2007
- Full Text
- View/download PDF
5. Staphylococcus aureus spa type t437: identification of the most dominant community-associated clone from Asia across Europe
- Author
-
Glasner, C., Pluister, G., Westh, H., Arends, J.P., Empel, J., Giles, E., Laurent, F., Layer, F., Marstein, L., Matussek, A., Mellmann, A., Pérez-Vásquez, M., Ungvári, E., Yan, X., Žemličková, H., Grundmann, H., and van Dijl, J.M.
- Published
- 2015
- Full Text
- View/download PDF
6. ACKNOWLEDGEMENT OF REVIEWERS
- Author
-
Adams, NG, Adekambi, T, Afeltra, J, Aguado, J, Aires de Sousa, M, Akiyoshi, K, Al Hasan, M, Ala-Kokko, T, Albert, M, Alfandari, S, Allen, D, Allerberger, F, Almyroudis, N, Alp, E, Amin, R, Anderson-Berry, A, Andes, DR, Andremont, A, Andreu, A, Angelakis, M, Antachopoulos, C, Antoniadou, A, Arabatzis, M, Arlet, G, Arnez, M, Arnold, C, Asensio, A, Asseray, N, Ausiello, C, Avni, T, Ayling, R, Baddour, L, Baguelin, M, Bányai, K, Barbour, A, Basco, LK, Bauer, D, Bayston, R, Beall, B, Becker, K, Behr, M, Bejon, P, Belliot, G, Benito-Fernandez, J, Benjamin, D, Benschop, K, Berencsi, G, Bergeron, MG, Bernard, K, Berner, R, Beyersmann, J, Bille, J, Bizzini, A, Bjarnsholt, T, Blanc, D, Blanco, J, Blot, S, Bohnert, J, Boillat, N, Bonomo, R, Bonten, M, Bordon, JM, Borel, N, Boschiroli, ML, Bosilkovski, M, Bosso, JA, Botelho-Nevers, E, Bou, G, Bretagne, S, Brouqui, P, Brun-Buisson, C, Brunetto, M, Bucher, H, Buchheidt, D, Buckling, A, Bulpa, P, Cambau, E, Canducci, F, Cantón, R, Capobianchi, M, Carattoli, A, Carcopino, X, Cardona-Castro, N, Carling, PC, Carrat, F, Castilla, J, Castilletti, C, Cavaco, L, Cavallo, R, Ceccherini-Silberstein, F, Centrón, D, Chappuis, F, Charrel, R, Chen, M, Chevaliez, S, Chezzi, C, Chomel, B, Chowers, M, Chryssanthou, E, Ciammaruconi, A, Ciccozzi, M, Cid, J, Ciofu, O, Cisneros, D, Ciufolini, MG, Clark, C, Clarke, SC, Clayton, R, Clementi, M, Clemons, K, Cloeckaert, Ael, Cloud, J, Coenye, T, Cohen Bacri, S, Cohen, R, Coia, J, Colombo, A, Colson, P, Concerse, P, Cordonnier, C, Cormican, M, Cornaglia, G, Cornely, O, Costa, S, Cots, F, Craxi, A, Creti, R, Crnich, C, Cuenca Estrella, M, Cusi, MG, d'Ettorre, G, da Cruz Lamas, C, Daikos, G, Dannaoui, E, De Barbeyrac, B, De Grazia, S, de Jager, C, de Lamballerie, X, de Marco, F, del Palacio, A, Delpeyroux, F, Denamur, E, Denis, O, Depaquit, J, Deplano, A, Desenclos, J-C, Desjeux, P, Deutch, S, Di Luca, D, Dianzani, F, Diep, B, Diestra, K, Dignani, C, Dimopoulos, G, Divizia, M, Doi, Y, Dornbusch, HJ, Dotis, J, Drancourt, M, Drevinek, P, Dromer, F, Dryden, M, Dubreuil, L, Dubus, J-C, Dumitrescu, O, Dumke, R, DuPont, H, Edelstein, M, Eggimann, P, Eis-Huebinger, A-M, El Atrouni, WI, Entenza, J, Ergonul, O, Espinel-Ingroff, A, Esteban, J, Etienne, J, Fan, X-G, Fenollar, F, Ferrante, P, Ferrieri, P, Ferry, T, Feuchtinger, T, Finegold, S, Fingerle, V, Fitch, M, Fitzgerald, R, Flori, P, Fluit, A, Fontana, R, Fournier, PE, François, M, Francois, P, Freedman, DO, Friedrich, A, Gallego, L, Gallinella, G, Gangneux, J-P, Gannon, V, Garbarg-Chenon, A, Garbino, J, Garnacho-Montero, J, Gatermann, Soeren, Gautret, P, Gentile, G, Gerlich, W, Ghannoum, M, Ghebremedhin, B, Ghigo, E, Giamarellos-Bourboulis, E, Girgis, R, Giske, C, Glupczynski, Y, Gnarpe, J, Gomez-Barrena, E, Gorwitz, RJ, Gosselin, R, Goubau, P, Gould, E, Gradel, K, Gray, J, Gregson, D, Greub, G, Grijalva, CG, Groll, A, Groschup, M, Gutiérrez, J, Hackam, DG, Hall, WA, Hallett, R, Hansen, S, Harbarth, S, Harf-Monteil, C, Hasanjani, Roushan MR, Hasler, P, Hatchette, T, Hauser, P, He, Q, Hedges, A, Helbig, J, Hennequin, C, Herrmann, B, Hezode, C, Higgins, P, Hoesli, I, Hoiby, N, Hope, W, Houvinen, P, Hsu, LY, Huard, R, Humphreys, H, Icardi, M, Imoehl, M, Ivanova, K, Iwamoto, T, Izopet, J, Jackson, Y, Jacobsen, K, Jang, TN, Jasir, A, Jaulhac, B, Jaureguy, F, Jefferies, JM, Jehl, F, Johnstone, J, Joly-Guillou, M-L, Jonas, M, Jones, M, Joukhadar, C, Kahl, B, Kaier, K, Kaiser, L, Kato, H, Katragkou, A, Kearns, A, Kern, W, Kerr, K, Kessin, R, Kibbler, C, Kimberlin, D, Kittang, B, Klaassen, C, Kluytmans, J, Ko, W-C, Koh, W-J, Kostrzewa, M, Kourbeti, I, Krause, R, Krcmery, V, Krizova, P, Kuijper, E, Kullberg, B-J, Kumar, G, Kunin, CM, La Scola, B, Lagging, M, Lagrou, K, Lamagni, T, Landini, P, Landman, D, Larsen, A, Lass-Floerl, C, Laupland, K, Lavigne, JP, Leblebicioglu, H, Lee, B, Lee, CH, Leggat, P, Lehours, P, Leibovici, Lonard, Leon, L, Leonard, N, Leone, M, Lescure, X, Lesprit, P, Levy, PY, Lew, D, Lexau, CA, Li, S-Y, Li, W, Lieberman, D, Lina, B, Lina, G, Lindsay, JA, Livermore, D, Lorente, L, Lortholary, O, Lucet, J-C, Lund, B, Lütticken, R, MacLeod, C, Madhi, S, Maertens, J, Maggi, F, Maiden, M, Maillard, J-Y, Maira-Litran, T, Maltezou, H, Manian, FA, Mantadakis, E, Maragakis, L, Marcelin, A-G, Marchaim, D, Marchetti, O, Marcos, M, Markotic, A, Martina, B, Martínez, J, Martinez, J-L, Marty, F, Maurin, M, McGee, L, Mediannikov, O, Meersseman, W, Megraud, F, Meletiadis, J, Mellmann, A, Meyer, E, Meyer, W, Meylan, P, Michalopoulos, A, Micol, R, Midulla, F, Mikami, Y, Miller, RF, Miragaia, M, Miriagou, V, Mitchell, TJ, Miyakis, S, Mokrousov, I, Monecke, S, Mönkemüller, K, Monno, L, Monod, M, Morales, G, Moriarty, F, Morosini, I, Mortensen, E, Mubarak, K, Mueller, B, Mühlemann, K, Muñoz Bellido, JL, Murray, P, Muscillo, M, Mylotte, J, Naessens, A, Nagy, E, Nahm, MH, Nassif, X, Navarro, D, Navarro, F, Neofytos, D, Nes, I, Ní Eidhin, D, Nicolle, L, Niederman, MS, Nigro, G, Nimmo, G, Nordmann, P, Nougairède, A, Novais, A, Nygard, K, Oliveira, D, Orth, D, Ortiz, JR, Osherov, N, Österblad, M, Ostrosky-Zeichner, L, Pagano, L, Palamara, AT, Pallares, R, Panagopoulou, P, Pandey, P, Panepinto, J, Pappas, G, Parkins, M, Parola, P, Pasqualotto, A, Pasteran, F, Paul, M, Pawlotsky, J-M, Peeters, M, Peixe, L, Pepin, J, Peralta, G, Pereyre, S, Perfect, JR, Petinaki, E, Petric, M, Pettigrew, M, Pfaller, M, Philipp, M, Phillips, G, Pichichero, M, Pierangeli, A, Pierard, D, Pigrau, C, Pilishvili, T, Pinto, F, Pistello, M, Pitout, J, Poirel, L, Poli, G, Poppert, S, Posfay-Barbe, K, Pothier, P, Poxton, I, Poyart, C, Pozzetto, B, Pujol, M, Pulcini, C, Punyadeera, C, Ramirez, M, Ranque, S, Raoult, D, Rasigade, J-P, Re, MC, Reilly, JS, Reinert, R, Renaud, B, Rice, L, Rich, S, Richet, H, Rigouts, L, Riva, E, Rizzo, C, Robotham, J, Rodicio, MR, Rodriguez, J, Rodriguez-Bano, J, Rogier, C, Roilides, E, Rolain, J-M, Rooijakkers, S, Rooney, P, Rossi, F, Rotimi, V, Rottman, M, Roux, V, Ruhe, J, Russo, G, Sadowy, E, Sagel, U, Said, SI, Saijo, M, Sak, B, Sa-Leao, R, Sanders, EAM, Sanguinetti, M, Sarrazin, C, Savelkoul, P, Scheifele, D, Schmidt, W-P, Schønheyder, H, Schönrich, G, Schrenzel, J, Schubert, S, Schwarz, K, Schwarz, S, Sefton, A, Segondy, M, Seifert, H, Seng, P, Senneville, E, Sexton, D, Shafer, RW, Shalit, I, Shankar, N, Shata, TM, Shields, J, Sibley, C, Sicinschi, L, Siljander, T, Simitsopoulou, M, Simoons-Smit, AM, Sissoko, D, Sjögren, J, Skiada, A, Skoczynska, A, Skov, R, Slack, M, Sogaard, M, Sola, C, Soriano, A, Sotto, A, Sougakoff, W, Souli, M, Spelberg, B, Spelman, D, Spiliopoulou, I, Springer, B, Stefani, S, Stein, A, Steinbach, WJ, Steinbakk, M, Strakova, L, Strenger, V, Sturm, P, Sullivan, P, Sutton, D, Symmons, D, Tacconelli, E, Tamalet, C, Tang, JW, Tang, Y-W, Tattevin, P, Thibault, V, Thomsen, RW, Thuny, F, Tong, S, Torres, C, Townsend, R, Tristan, A, Trouillet, J-L, Tsai, H-C, Tsitsopoulos, P, Tuerlinckx, D, Tulkens, P, Tumbarello, M, Tureen, J, Turnidge, JD, Turriziani, O, Tutuian, R, Uçkay, I, Upton, M, Vabret, A, Vamvakas, EC, van den Boom, D, Van Eldere, J, van Leeuwen, W, van Strijp, J, Van Veen, S, Vandamme, P, Vandenesch, F, Vayssier, M, Velin, D, Venditti, M, Venter, M, Venuti, A, Vergnaud, G, Verheij, T, Verhofstede, C, Viscoli, C, Vizza, CD, Vogel, U, Waller, A, Wang, YF, Warn, P, Warris, A, Wauters, G, Weidmann, M, Weill, F-X, Weinberger, M, Welch, D, Wellinghausen, N, Wheat, J, Widmer, A, Wild, F, Willems, R, Willinger, B, Winstanley, C, Witte, W, Wolff, M, Wong, F, Wootton, M, Wyllie, D, Xu, W, Yamamoto, S, Yaron, S, Yildirim, I, Zaoutis, T, Zazzi, M, Zbinden, R, Zehender, Gianguglielmo G, Zemlickova, H, Zerbini, ML, Zhang, L, Zhang, Y, Zhao, Y-D, Zhu, Z, and Zimmerli, W
- Published
- 2011
- Full Text
- View/download PDF
7. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
- Author
-
Cassini, A, Hogberg, LD, Plachouras, D, Quattrocchi, A, Hoxha, A, Simonsen, GS, Colomb-Cotinat, M, Kretzschmar, ME, Devleesschauwer, B, Cecchini, M, Ouakrim, DA, Oliveira, TC, Struelens, MJ, Suetens, C, Monnet, DL, Strauss, R, Mertens, K, Struyf, T, Catry, B, Latour, K, Ivanov, IN, Dobreva, EG, Tambic Andrasevic, A, Soprek, S, Budimir, A, Paphitou, N, Zemlickova, H, Olsen, SS, Sonksen, UW, Martin, P, Ivanova, M, Lyytikainen, O, Jalava, J, Coignard, B, Eckmanns, T, Abu Sin, M, Haller, S, Daikos, GL, Gikas, A, Tsiodras, S, Kontopidou, F, Toth, A, Hajdu, A, Guolaugsson, O, Kristinsson, KG, Murchan, S, Burns, K, Dsstat, PP, Gagliotti, C, Dumpis, U, Liuimiene, A, Perrin, M, Borg, MA, de Greeff, SC, Monen, JCM, Koek, MBG, Elstrom, P, Zabicka, D, Deptula, A, Hryniewicz, W, Canica, M, Nogueira, PJ, Fernandes, PA, Manageiro, V, Popescu, GA, Serban, RI, Schreterova, E, Litvova, S, Stefkovicova, M, Kolman, J, Klavs, I, Korosec, A, Aracil, B, Asensio, A, Perez-Vazquez, M, Billstrom, H, Larsson, S, Reilly, JS, Johnson, A, Hopkins, S, Cassini, A, Hogberg, LD, Plachouras, D, Quattrocchi, A, Hoxha, A, Simonsen, GS, Colomb-Cotinat, M, Kretzschmar, ME, Devleesschauwer, B, Cecchini, M, Ouakrim, DA, Oliveira, TC, Struelens, MJ, Suetens, C, Monnet, DL, Strauss, R, Mertens, K, Struyf, T, Catry, B, Latour, K, Ivanov, IN, Dobreva, EG, Tambic Andrasevic, A, Soprek, S, Budimir, A, Paphitou, N, Zemlickova, H, Olsen, SS, Sonksen, UW, Martin, P, Ivanova, M, Lyytikainen, O, Jalava, J, Coignard, B, Eckmanns, T, Abu Sin, M, Haller, S, Daikos, GL, Gikas, A, Tsiodras, S, Kontopidou, F, Toth, A, Hajdu, A, Guolaugsson, O, Kristinsson, KG, Murchan, S, Burns, K, Dsstat, PP, Gagliotti, C, Dumpis, U, Liuimiene, A, Perrin, M, Borg, MA, de Greeff, SC, Monen, JCM, Koek, MBG, Elstrom, P, Zabicka, D, Deptula, A, Hryniewicz, W, Canica, M, Nogueira, PJ, Fernandes, PA, Manageiro, V, Popescu, GA, Serban, RI, Schreterova, E, Litvova, S, Stefkovicova, M, Kolman, J, Klavs, I, Korosec, A, Aracil, B, Asensio, A, Perez-Vazquez, M, Billstrom, H, Larsson, S, Reilly, JS, Johnson, A, and Hopkins, S
- Abstract
BACKGROUND: Infections due to antibiotic-resistant bacteria are threatening modern health care. However, estimating their incidence, complications, and attributable mortality is challenging. We aimed to estimate the burden of infections caused by antibiotic-resistant bacteria of public health concern in countries of the EU and European Economic Area (EEA) in 2015, measured in number of cases, attributable deaths, and disability-adjusted life-years (DALYs). METHODS: We estimated the incidence of infections with 16 antibiotic resistance-bacterium combinations from European Antimicrobial Resistance Surveillance Network (EARS-Net) 2015 data that was country-corrected for population coverage. We multiplied the number of bloodstream infections (BSIs) by a conversion factor derived from the European Centre for Disease Prevention and Control point prevalence survey of health-care-associated infections in European acute care hospitals in 2011-12 to estimate the number of non-BSIs. We developed disease outcome models for five types of infection on the basis of systematic reviews of the literature. FINDINGS: From EARS-Net data collected between Jan 1, 2015, and Dec 31, 2015, we estimated 671 689 (95% uncertainty interval [UI] 583 148-763 966) infections with antibiotic-resistant bacteria, of which 63·5% (426 277 of 671 689) were associated with health care. These infections accounted for an estimated 33 110 (28 480-38 430) attributable deaths and 874 541 (768 837-989 068) DALYs. The burden for the EU and EEA was highest in infants (aged <1 year) and people aged 65 years or older, had increased since 2007, and was highest in Italy and Greece. INTERPRETATION: Our results present the health burden of five types of infection with antibiotic-resistant bacteria expressed, for the first time, in DALYs. The estimated burden of infections with antibiotic-resistant bacteria in the EU and EEA is substantial compared with that of other infectious diseases, and has increased since 2007. Ou
- Published
- 2019
8. Results from the Survey of Antibiotic Resistance (SOAR) 2014–16 in the Czech Republic
- Author
-
Torumkuney, D, primary, Zemlickova, H, additional, Maruscak, M, additional, and Morrissey, I, additional
- Published
- 2018
- Full Text
- View/download PDF
9. Report on a transborder spread of carbapenemase-producing bacteria by a patient injured during Euromaidan, Ukraine
- Author
-
Hrabák, J., Študentová, V., Adámková, V., Šemberová, L., Kabelíková, P., Hedlová, D., Čurdová, M., Zemlickova, H., and Papagiannitsis, C.C.
- Published
- 2015
- Full Text
- View/download PDF
10. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe
- Author
-
Struelens, M. J., Monnet, D. L., Magiorakos, A. P., Santos O'Connor, F., Giesecke, J., Grisold, A., Zarfel, G., Jans, B., Velinov, T., Kantardjiev, T., Alexandrou, M., Zemlickova, H., Hrabak, J., Frimodt Møller, N., Hammerum, A. M., Maimets, M., Ivanova, M., Jalava, J., Rummukainen, M., Eckmanns, T., Kaase, M., Dedoukou, X., Vatopoulos, A., Böröcz, K., Kristinsson, K. G., Gudlaugsson, O., Cunney, R., Rossolini, GIAN MARIA, Pantosti, A., Dumpis, U., Balode, A., Valinteliene, R., Weicherding, P., Leverstein van Hall, M. A., Huijsdens, X., Samuelsen, Ø., Simonsen, G. S., Hryniewicz, W., Gniadkowski, M., Costa, A. C., Caniça, M., Codita, I., Serban, R., Siegfried, L., Stefkovicova, M., Kolman, J., Pirš, M., Oteo, J., Campos, J., Tegmark Wisell, K., Edquist, P., Livermore, D., and Woodford, N.
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pediatrics ,Adolescent ,Epidemiology ,Prevalence ,Guidelines as Topic ,Microbial Sensitivity Tests ,Polymerase Chain Reaction ,Risk Assessment ,beta-Lactamases ,Young Adult ,Antibiotic resistance ,Enterobacteriaceae ,Virology ,Environmental health ,Surveys and Questionnaires ,Health care ,medicine ,media_common.cataloged_instance ,Humans ,Beta-lactamase ,European union ,Child ,Disease Notification ,media_common ,Aged ,Aged, 80 and over ,biology ,business.industry ,Resistência aos Antimicrobianos ,Public health ,Incidence ,Public Health, Environmental and Occupational Health ,Enterobacteriaceae Infections ,Middle Aged ,New Delhi metallo-beta-lactamase 1 ,Europe ,Phenotype ,Carbapenems ,Child, Preschool ,Population Surveillance ,biology.protein ,business - Abstract
The European NDM-1 Survey Participants: Manuela Caniça (Departamento de Doenças Infecciosas do INSA) Acquired carbapenemases confer extensive antibiotic resistance to Enterobacteriaceae and represent a public health threat. A novel acquired carbapenemase, New Delhi metallo-beta-lactamase 1 (NDM-1), has recently been described in the United Kingdom and Sweden, mostly in patients who had received care on the Indian subcontinent. We conducted a survey among 29 European countries (the European Union Member States, Iceland and Norway) to gather information on the spread of NDM-1-producing Enterobacteriaceae in Europe, on public health responses and on available national guidance on detection, surveillance and control. A total of 77 cases were reported from 13 countries from 2008 to 2010. Klebsiella pneumoniae was the most frequently reported species with 54%. Among 55 cases with recorded travel history, 31 had previously travelled or been admitted to a hospital in India or Pakistan and five had been hospitalised in the Balkan region. Possible nosocomial acquisition accounted for 13 of 77 cases. National guidance on NDM-1 detection was available in 14 countries and on NDM-1 control in 11 countries. In conclusion, NDM-1 is spreading across Europe, where it is frequently linked to a history of healthcare abroad, but also to emerging nosocomial transmission. National guidance in response to the threat of carbapenemase-producing Enterobacteriaceae is available in approximately half of the surveyed European countries. Surveillance of carbapenemase- producing Enterobacteriaceae must be enhanced in Europe and effective control measures identified and implemented.
- Published
- 2010
11. A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic
- Author
-
Holden, M.T.G., Hsu, L-Y, Kurt, K., Weinert, L.A., Mather, A.E., Harris, S.R., Strommenger, B., Layer, F., Witte, W., de Lencastre, H., Skov, R., Westh, H., Zemlickova, H., Coombs, G., Kearns, A.M., Hill, R.L.R., Edgeworth, J., Gould, I., Gant, V., Cooke, J., Edwards, G.F., McAdam, P.R., Templeton, K.E., McCann, A., Zhou, Z., Castillo-Ramirez, S., Feil, E.J., Hudson, L.O., Enright, M.C., Balloux, F., Aanensen, D.M., Spratt, B.G., Fitzgerald, J.R., Parkhill, J., Achtman, M., Bentley, S.D., Nubel, U., Holden, M.T.G., Hsu, L-Y, Kurt, K., Weinert, L.A., Mather, A.E., Harris, S.R., Strommenger, B., Layer, F., Witte, W., de Lencastre, H., Skov, R., Westh, H., Zemlickova, H., Coombs, G., Kearns, A.M., Hill, R.L.R., Edgeworth, J., Gould, I., Gant, V., Cooke, J., Edwards, G.F., McAdam, P.R., Templeton, K.E., McCann, A., Zhou, Z., Castillo-Ramirez, S., Feil, E.J., Hudson, L.O., Enright, M.C., Balloux, F., Aanensen, D.M., Spratt, B.G., Fitzgerald, J.R., Parkhill, J., Achtman, M., Bentley, S.D., and Nubel, U.
- Abstract
The widespread use of antibiotics in association with high-density clinical care has driven the emergence of drugresistant bacteria that are adapted to thrive in hospitalized patients. Of particular concern are globally disseminated methicillin-resistant Staphylococcus aureus (MRSA) clones that cause outbreaks and epidemics associated with health care. The most rapidly spreading and tenacious health-care-associated clone in Europe currently is EMRSA-15, which was first detected in the UK in the early 1990s and subsequently spread throughout Europe and beyond. Using phylogenomic methods to analyze the genome sequences for 193 S. aureus isolates, we were able to show that the current pandemic population of EMRSA-15 descends from a health-care-associatedMRSA epidemic that spread throughout England in the 1980s, which had itself previously emerged froma primarily community-associated methicillin-sensitive population. The emergence of fluoroquinolone resistance in this EMRSA-15 subclone in the English Midlands during the mid-1980s appears to have played a key role in triggering pandemic spread, and occurred shortly after the first clinical trials of this drug. Genome-based coalescence analysis estimated that the population of this subclone over the last 20 yr has grown four times faster than its progenitor. Using comparative genomic analysis we identified the molecular genetic basis of 99.8% of the antimicrobial resistance phenotypes of the isolates, highlighting the potential of pathogen genome sequencing as a diagnostic tool.We document the genetic changes associated with adaptation to the hospital environment and with increasing drug resistance over time, and how MRSA evolution likely has been influenced by country-specific drug use regimens.
- Published
- 2013
12. A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic
- Author
-
Holden, M., Hsu, L., Kurt, K., Weinert, L., Mather, A., Harris, S., Strommenger, B., Layer, F., Witte, W., de Lencastre, H., Skov, R., Westh, H., Zemlickova, H., Coombs, Geoffrey, Kearns, A., Hill, R., Edgeworth, J., Gould, I., Gant, V., Cooke, J., Edwards, G., McAdam, P., Templeton, K., McCann, A., Zhou, Z., Castillo-Ramirez, S., Feil, E., Hudson, L., Enright, M., Balloux, F., Aanensen, D., Spratt, B., Fitzgerald, J., Parkhill, J., Achtman, M., Bentley, S., Nubel, U., Holden, M., Hsu, L., Kurt, K., Weinert, L., Mather, A., Harris, S., Strommenger, B., Layer, F., Witte, W., de Lencastre, H., Skov, R., Westh, H., Zemlickova, H., Coombs, Geoffrey, Kearns, A., Hill, R., Edgeworth, J., Gould, I., Gant, V., Cooke, J., Edwards, G., McAdam, P., Templeton, K., McCann, A., Zhou, Z., Castillo-Ramirez, S., Feil, E., Hudson, L., Enright, M., Balloux, F., Aanensen, D., Spratt, B., Fitzgerald, J., Parkhill, J., Achtman, M., Bentley, S., and Nubel, U.
- Abstract
The widespread use of antibiotics in association with high-density clinical care has driven the emergence of drugresistant bacteria that are adapted to thrive in hospitalized patients. Of particular concern are globally disseminated methicillin-resistant Staphylococcus aureus (MRSA) clones that cause outbreaks and epidemics associated with health care. The most rapidly spreading and tenacious health-care-associated clone in Europe currently is EMRSA-15, which was first detected in the UK in the early 1990s and subsequently spread throughout Europe and beyond. Using phylogenomic methods to analyze the genome sequences for 193 S. aureus isolates, we were able to show that the current pandemic population of EMRSA-15 descends from a health-care-associatedMRSA epidemic that spread throughout England in the 1980s, which had itself previously emerged froma primarily community-associated methicillin-sensitive population. The emergence of fluoroquinolone resistance in this EMRSA-15 subclone in the English Midlands during the mid-1980s appears to have played a key role in triggering pandemic spread, and occurred shortly after the first clinical trials of this drug. Genome-based coalescence analysis estimated that the population of this subclone over the last 20 yr has grown four times faster than its progenitor. Using comparative genomic analysis we identified the molecular genetic basis of 99.8% of the antimicrobial resistance phenotypes of the isolates, highlighting the potential of pathogen genome sequencing as a diagnostic tool.We document the genetic changes associated with adaptation to the hospital environment and with increasing drug resistance over time, and how MRSA evolution likely has been influenced by country-specific drug use regimens
- Published
- 2013
13. Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe.
- Author
-
Cleef, B.A. van, Monnet, D.L., Voss, A., Krziwanek, K., Allerberger, F., Struelens, M., Zemlickova, H., Skov, R.L., Vuopio-Varkila, J., Cuny, C., Friedrich, A.W., Spiliopoulou, I., Paszti, J., Hardardottir, H., Rossney, A., Pan, A., Pantosti, A., Borg, M., Grundmann, H., Mueller-Premru, M., Olsson-Liljequist, B., Widmer, A., Harbarth, S., Schweiger, A., Unal, S., Kluytmans, J.A., Cleef, B.A. van, Monnet, D.L., Voss, A., Krziwanek, K., Allerberger, F., Struelens, M., Zemlickova, H., Skov, R.L., Vuopio-Varkila, J., Cuny, C., Friedrich, A.W., Spiliopoulou, I., Paszti, J., Hardardottir, H., Rossney, A., Pan, A., Pantosti, A., Borg, M., Grundmann, H., Mueller-Premru, M., Olsson-Liljequist, B., Widmer, A., Harbarth, S., Schweiger, A., Unal, S., and Kluytmans, J.A.
- Abstract
1 maart 2011, Contains fulltext : 96061.pdf (publisher's version ) (Open Access), To estimate the proportion of methicillin-resistant Staphylococcus aureus (MRSA) isolates from humans that were sequence type (ST) 398, we surveyed 24 laboratories in 17 countries in Europe in 2007. Livestock-associated MRSA ST398 accounted for only a small proportion of MRSA isolates from humans; most were from the Netherlands, Belgium, Denmark, and Austria.
- Published
- 2011
14. Rapid evolution of methicillin-resistant Staphylococcus aureus: genome variation traces epidemic spread
- Author
-
Nubel, U., Dordel, J., Kurt, K., Strommenger, B., Westh, Henrik T., Shukla, S.K., Berger-Bachi, B., Zemlickova, H., Witte, W., Nubel, U., Dordel, J., Kurt, K., Strommenger, B., Westh, Henrik T., Shukla, S.K., Berger-Bachi, B., Zemlickova, H., and Witte, W.
- Published
- 2009
15. NDM-1 producing Acinetobacter baumannii isolated from a patient repatriated to the Czech Republic from Egypt, July 2011
- Author
-
Hrabák, J, primary, Štolbová, M, additional, Študentová, V, additional, Fridrichová, M, additional, Chudáčková, E, additional, and Zemlickova, H, additional
- Published
- 2012
- Full Text
- View/download PDF
16. First identification of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Czech Republic
- Author
-
Hrabák, J, primary, Fridrichová, M, additional, Štolbová, M, additional, Bergerová, T, additional, Zemlickova, H, additional, and Urbaskova, P, additional
- Published
- 2009
- Full Text
- View/download PDF
17. P1848 Molecular epidemiology of Streptococcus pneumoniae asso-ciated with paediatric invasive disease in the Czech Republic
- Author
-
Zemlickova, H., primary, Jakubu, V., additional, Urbaskova, P., additional, Musilek, M., additional, and Motlova, J., additional
- Published
- 2007
- Full Text
- View/download PDF
18. P1000 Molecular characterisation of penicillin non-susceptible invasive strains of Streptococcus pneumoniae prevalent in the Czech Republic
- Author
-
Jakubu, V., primary, Zemlickova, H., additional, Urbaskova, P., additional, and Kasik, J., additional
- Published
- 2007
- Full Text
- View/download PDF
19. Emergence of EMRSA-15 clone in hospitals throughout the Czech Republic
- Author
-
Melter, O, primary, Urbaskova, P, additional, Jakubu, V, additional, Mackova, B, additional, Zemlickova, H, additional, and Czech participants in EARSS, Collective, additional
- Published
- 2006
- Full Text
- View/download PDF
20. Carbapenemase-producing Klebsiella pneumoniae in the Czech Republic in 2011.
- Author
-
Hrabák, J., Papagiannitsis, C. C., Študentová, V., Jakubu, V., Fridrichová, M., and Zemlickova, H.
- Published
- 2013
21. Methicillin-Resistant Staphylococcus aureusClonal Types in the Czech Republic
- Author
-
Melter, O., Santos Sanches, I., Schindler, J., Aires de Sousa, M., Mato, R., Kova´rova, V., Zemlickova´, H., and de Lencastre, H.
- Abstract
ABSTRACTMolecular surveillance studies have documented the extensive spread of methicillin-resistant Staphylococcus aureus(MRSA) clones. Studies carried out by Centro de Epidemiologia Molecular-Network for Tracking Gram-Positive Pathogenic Bacteria (CEM/NET) led to the identification of two international multidrug-resistant strains, which were designated as the Iberian and Brazilian MRSA clones and which were defined by multiple genomic typing methods; these included ClaI restriction digests hybridized with mecA- and Tn554-specific DNA probes and pulsed-field gel electrophoresis (PFGE). The genotypic characteristics of these clones are distinct: the Iberian clone is defined asmecAtype I, Tn554type E (or its variants), and PFGE pattern A (I:E:A), whereas the Brazilian clone is defined asmecAtype XI (or its variants), Tn554type B, and PFGE pattern B (XI:B:B). In this study, we characterized 59 single-patient isolates of MRSA collected during 1996 and 1997 at seven hospitals located in Prague and five other cities in the Czech Republic by using the methodologies mentioned above and by using ribotyping ofEcoRI and HindIII digests hybridized with a 16S-23S DNA probe. The Brazilian MRSA clone (XI:B:B) was the major clone (80%) spread in two hospitals located in Prague and one located in Brno; the Iberian MRSA clone (I:E:A or its variant I:DD:A), although less representative (12%), was detected in two hospitals, one in Prague and the other in Plzen. Almost all the strains belonging to clone XI:B:B (45 of 47) corresponded to a unique ribotype, E1H1, whereas most strains of the I:E:A and I:DD:A clonal types (6 of 7) corresponded to ribotype E2H2.
- Published
- 1999
- Full Text
- View/download PDF
22. Carbapenemase-producing Klebsiella pneumoniae in the Czech Republic in 2011
- Author
-
Hrabák, J., Costas Papagiannitsis, Študentová, V., Jakubu, V., Fridrichová, M., Zemlickova, H., and Czech Participants of European Antimicrobial Resistance Surveillance Network
23. Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals - results from Czech Part of European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE)
- Author
-
Hrabak, J., Studentova, V., Jakubu, V., Adamkova, V., Dvorakova, L., Balejova, M., Bergerova, T., Chmelarova, E., Petr Jezek, Kabelikova, P., Kolar, M., Paterova, P., Tejkalova, R., Papagiannitsis, C., and Zemlickova, H.
24. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: Emergence and response in Europe
- Author
-
Struelens, M. J., Monnet, D. L., Magiorakos, A. P., Santos O Connor, F., Giesecke, J., Grisold, A., Zarfel, G., Jans, B., Velinov, T., Kantardjiev, T., Alexandrou, M., Zemlickova, H., Hrabak, J., Frimodt-Møller, N., Hammerum, A. M., Maimets, M., Ivanova, M., Jalava, J., Rummukainen, M., Eckmanns, T., Kaase, M., Dedoukou, X., Vatopoulos, A., Böröcz, K., Kristinsson, K. G., Gudlaugsson, O., Cunney, R., Rossolini, G. M., Annalisa Pantosti, Dumpis, U., Balode, A., Valinteliene, R., Weicherding, P., Borg, M., Leverstein-Van Hall, M., Huijsdens, X., Samuelsen, Ø., Simonsen, G. S., Hryniewicz, W., Gniadkowski, M., Costa, A. C., Caniça, M., Codita, I., Serban, R., Siegfried, L., Stefkovicova, M., Kolman, J., Pirš, M., Oteo, J., Campos, J., Tegmark-Wisell, K., Edquist, P., Livermore, D., and Woodford, N.
25. Carbapenem-non-susceptible Enterobacteriaceae in Europe: Conclusions from a meeting of national experts
- Author
-
Grundmann, H., Livermore, D. M., Giske, C. G., Canton, R., Rossolini, G. M., Campos, J., Vatopoulos, A., Gniadkowski, M., Toth, A., Pfeifer, Y., Jarlier, V., Carmeli, Y., Mittermayer, H., Goossens, M., Tihic, N., Proevska, Y., Tambic, A., Pieridou-Bagatzouni, D., Zemlickova, H., Hrabak, J., Hammerum, A. M., Ivanova, M., Jalavi, J., Hardarson, H., Wee Boo, T., Colodner, R., Monaco, M., Aurora García-Fernández, Rossolini, G., Balode, A., Miciuleviciene, J., Caruana, P., Skov, G., Samuelsen, O., Hryniewicz, W., Caniça, M., Manageiro, V., Codita, I., Mueller-Premru, M., Kolman, J., Oteo Iglesias, J., Cantón, R., Edquist, P. J., Giske, C., Droz, S., Livermore, D., Leverstein-Van Hall, M. A., and Huijsdens, X.
26. Carbapenemase-producing Klebsiella pneumoniae in the Czech Republic in 2011
- Author
-
Hrabák, J., Papagiannitsis, C. C., Študentová, V., Jakubu, V., Fridrichová, M., Zemlickova, H., Adamkova, V., Bartonikova, N., Bartova, M., Bendova, E., Bergerova, T., Bohunova, Z., Capova, E., Chmelarova, E., Dovalova, M., Glasnak, M., Hanslianova, M., Haskova, V., Heinigeova, B., Hornikova, M., Horova, B., Janeckova, J., Jezek, P., Jindrak, V., Kolar, M., Kolarova, L., Kůrková, V., Linhart, P., Nedvedova, H., Niemczykova, J., Nyc, O., Petkov, V., Pokorna, Z., Pomykal, J., Puchalkova, B., Rumlerova, M., Ryskova, L., Scharfen, J., Sekacova, A., Skacaniova, H., Simeckova, E., Sosikova, M., Stastna, E., Steinerova, A., Stolbova, M., Tejkalova, R., Trojan, L., Typovska, H., Uhlirova, E., Vesela, E., Zalabska, E., Zamazalova, D., and Zaruba, R.
27. Carbapenem-non-susceptible Enterobacteriaceae in Europe: Conclusions from a meeting of national experts
- Author
-
Grundmann, H., Livermore, D. M., Giske, C. G., Canton, R., Rossolini, G. M., Campos, J., Vatopoulos, A., Gniadkowski, M., Toth, A., Pfeifer, Y., Jarlier, V., Carmeli, Y., Mittermayer, H., Goossens, M., Tihic, N., Proevska, Y., Tambic, A., Pieridou-Bagatzouni, D., Zemlickova, H., Hrabak, J., Hammerum, A. M., Ivanova, M., Jalavi, J., Hardarson, H., Wee Boo, T., Colodner, R., Monaco, M., Garcia-Fernandez, A., Rossolini, G., Balode, A., Miciuleviciene, J., Caruana, P., Skov, G., Samuelsen, O., Hryniewicz, W., Manuela Caniça, Manageiro, V., Codita, I., Mueller-Premru, M., Kolman, J., Oteo Iglesias, J., Cantón, R., Edquist, P. J., Giske, C., Droz, S., Livermore, D., Leverstein-Van Hall, M. A., and Huijsdens, X.
28. The dynamic changes of dominant clones of Staphylococcus aureus causing bloodstream infections in the European region: Results of a second structured survey
- Author
-
Grundmann, H, Schouls, L M, Aanensen, D M, Pluister, G N, Tami, A, Chlebowicz, M, Glasner, C, Sabat, A J, Weist, K, Heuer, O, Friedrich, A W, ESCMID Study Group on Molecular Epidemiological Markers, European Staphylococcal Reference Laboratory Working Group, Perez-Vazquez, Maria, Unión Europea. European Centre for Disease Prevention and Control (ECDC), ESCMID Study Group on Molecular Epidemiological Markers, European Staphylococcal Reference Laboratory Working Group, Denis, O., Nashev, D., Blanc, D.S., Pieridou-Bagatzouni, D., Jakubu, V., Zemlickova, H., Westh, H., Larsen, A.R., Skov, R., Laurent, F., Layer, F., Witte, W., Spiliopoulou, I., Salmenlinna, S., Lindholm, L., Vuopio-Varkila, J., Toth, A., Ungvari, E., Brennan, G., Shore, A., Miklasevics, E., Balode, A., Haraldsson, G., Kristinsson, K.G., Monaco, M., Pantosti, A., Borg, M., Huijsdens, X., Heck, M., Marstein, L., Jacobsen, T., Gran, F., Faria, N., de Lencastre, H., Empel, J., Kozińska, A., Hryniewicz, W., Codita, I., Perez-Vazquez, M., Vindel, A., Švent Kučina, N., Haeggman, S., Liljequist, B.O., Pichon, B., Kearns, A., Edwards, G., and Microbes in Health and Disease (MHD)
- Subjects
Male ,Methicillin-Resistant Staphylococcus aureus ,Staphylococcus aureus ,medicine.medical_specialty ,Genotype ,Epidemiology ,Human pathogen ,Microbial Sensitivity Tests ,medicine.disease_cause ,Microbiology ,EMERGENCE ,Virology ,medicine ,Humans ,Typing ,Staphylococcal Protein A ,Anti-Bacterial Agents/pharmacology ,Bacterial Typing Techniques ,Data Collection ,Europe ,Female ,Genetic Variation ,Molecular Epidemiology ,Multilocus Sequence Typing ,Staphylococcal Infections/blood ,Staphylococcal Infections/epidemiology ,Staphylococcal Infections/microbiology ,Staphylococcal Protein A/genetics ,Staphylococcus aureus/classification ,Staphylococcus aureus/drug effects ,Staphylococcus aureus/genetics ,Staphylococcus aureus/isolation & purification ,Molecular epidemiology ,business.industry ,Public Health, Environmental and Occupational Health ,Staphylococcal Infections ,Methicillin-resistant Staphylococcus aureus ,Anti-Bacterial Agents ,Multilocus sequence typing ,SPREAD ,business - Abstract
Staphylococcus aureus is one of the most important human pathogens and meticillin-resistant S. aureus (MRSA) presents a major cause of healthcare- and community-acquired infections. This study investigated the spatial and temporal changes of S. aureus causing bacteraemia in Europe over a five-year interval and explored the possibility of integrating pathogen-based typing data with epidemiological and clinical information at a European level. Between January 2011 and July 2011, 350 laboratories serving 453 hospitals in 25 countries collected 3,753 isolates (meticillin-sensitive S. aureus (MSSA) and MRSA) from patients with S. aureus bloodstream infections. All isolates were sent to the national staphylococcal reference laboratories and characterised by quality-controlled spa typing. Data were uploaded to an interactive web-based mapping tool. A wide geographical distribution of spa types was found, with some prevalent in all European countries. MSSA was more diverse than MRSA. MRSA differed considerably between countries with major international clones expanding or receding when compared to a 2006 survey. We provide evidence that a network approach of decentralised typing and visualisation of aggregated data using an interactive mapping tool can provide important information on the dynamics of S. aureus populations such as early signalling of emerging strains, cross-border spread and importation by travel. The study was funded by ECDC through tender and frame-work contract ECDC 09/033. Sí
- Published
- 2014
- Full Text
- View/download PDF
29. Amino acid substitutions in PBP3 in Haemophilus influenzae strains, their phenotypic detection and impact on resistance to β-lactams.
- Author
-
Jakubu V, Cechova M, Musilek M, Malisova L, Zapletalova B, and Zemlickova H
- Abstract
Background: Data from surveillance on antibiotic resistance have shown an increasing prevalence of non-enzymatic resistance (β-lactamase-negative ampicillin-resistant) to β-lactam antibiotics among H. influenzae strains in the Czech Republic. Aminopenicillins are recommended agents for non-invasive Haemophilus influenzae infections. The phenomenon of non-enzymatic resistance to β-lactams is complicated by the fact that the phenotypic detection of PBP3 with specific amino acid substitutions (rPBP3) is challenging, since rPBP3 isolates have repeatedly been demonstrated to be split by the epidemiological cut-off values (ECOFF) for aminopenicillins defined by EUCAST., Objectives: We sought to determine whether the penicillin disc has sufficient detection ability to predict the non-enzymatic mechanism; whether other antibiotics can be used for detection; and what is the agreement between the broth microdilution and disc diffusion methods., Methods: We undertook susceptibility testing of selected antibiotics according to EUCAST of 153 rPBP3 strains, and sequencing of the ftsI gene to determination amino acid substitutions., Results: For a selected set of rPBP strains: (i) the detection capability for penicillin, ampicillin, cefuroxime and amoxicillin/clavulanate was found to be 91.5%, 94.4%, 89.5% and 70.6%, respectively; (ii) the categorical agreement between the disc diffusion method and the MIC for ampicillin and cefuroxime was 71.1% and 83.8%, respectively., Conclusions: We observed better recognition of rPBP3 strains by the ampicillin disc than by the penicillin disc. There is frequently a discrepancy in the interpretation of susceptibility results between the methods used., (© The Author(s) 2025. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.)
- Published
- 2025
- Full Text
- View/download PDF
30. Whole-genome sequence analysis of morphological changes in Haemophilus influenzae after beta-lactam exposure.
- Author
-
Malisova L, Jakubu V, Bitar I, Krsek D, and Zemlickova H
- Subjects
- Humans, Mutation, Ampicillin pharmacology, Microbial Sensitivity Tests, Cefuroxime pharmacology, Whole Genome Sequencing, Anti-Bacterial Agents pharmacology, Haemophilus influenzae genetics, Haemophilus influenzae drug effects, beta-Lactams pharmacology, Genome, Bacterial
- Abstract
This report describes mutations in genes responsible for cell deformities in haemophili under beta-lactam pressure in vitro. Light and transmission electron microscopy confirmed a hypothesis regarding changes in the shape of haemophili that had become more filamentous in the presence of ampicillin (2 mg/L) and cefuroxime (8 mg/L) after 30 days of serial passage. Short-axis size increased by 28% (from 0.767 to 1.06 µm) and long-axis length increased by 54% (from 1 to 2.175 µm). Additionally, whole-genome sequencing analysis (Illumina platform, software PROKKA) revealed a variety of mutations in genes responsible for cell morphology in isolates examined in this study: ftsI (A1576 → C; G1154 → C; T986 → C; G1684 → C), mreB (C476 → T), mreC (A5 → G), mrdA (A1148 → G; C179 → T; G1613 → T), mrdB (T668 → G), mltC (C1016 → T) and rodA (T668 → G). The results of this study indicate that shifts in bacterial shape could play a role in the adaptation of haemophili to a new niche created by beta-lactams as a strategy of antibiotic therapy survival., Competing Interests: Declaration of competing interests None declared., (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
31. Evolution of mutations in the ftsI gene leading to amino acid substitutions in PBP3 in Haemophilus influenzae strains under the selective pressure of ampicillin and cefuroxime.
- Author
-
Jakubu V, Vrbova I, Bitar I, Cechova M, Malisova L, and Zemlickova H
- Subjects
- Humans, Bacterial Proteins genetics, Bacterial Proteins metabolism, Haemophilus Infections microbiology, Whole Genome Sequencing, Evolution, Molecular, Selection, Genetic, Serial Passage, Cefuroxime pharmacology, Ampicillin pharmacology, Haemophilus influenzae genetics, Haemophilus influenzae drug effects, Microbial Sensitivity Tests, Penicillin-Binding Proteins genetics, Penicillin-Binding Proteins metabolism, Anti-Bacterial Agents pharmacology, Amino Acid Substitution, Mutation
- Abstract
Background: Aminopenicillins are recommended agents for non-invasive Haemophilus influenzae infections. One of the mechanisms of resistance to β-lactams is the alteration of the transpeptidase region of penicillin binding protein 3 (PBP3) which is caused by mutations in the ftsI gene. It was shown that exposure to beta-lactams has a stimulating effect on increase of prevalence of H. influenzae strains with the non-enzymatic mechanism of resistance., Objectives: The aim of our study was to compare the mutational potential of ampicillin and cefuroxime in H. influenzae strains, determination of minimum inhibitory concentration and the evolution of mutations over time, focusing on amino acid substitutions in PBP3., Methods: 30 days of serial passaging of strains in liquid broth containing increasing concentrations of ampicillin or cefuroxime was followed by whole-genome sequencing., Results: On average, cefuroxime increased the minimum inhibitory concentration more than ampicillin. The minimum inhibitory concentration was increased by a maximum of 32 fold. Substitutions in the PBP3 started to appear after 15 days of passaging. In PBP3, cefuroxime caused different substitutions than ampicillin., Conclusions: Our experiment observed differences in mutation selection by ampicillin and cefuroxime. Selection pressure of antibiotics in vitro generated substitutions that do not occur in clinical strains in the Czech Republic., Competing Interests: Conflict of Interest The authors declare no conflict of interest., (Copyright © 2024 The Authors. Published by Elsevier GmbH.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
32. In Vitro Activity of Cefiderocol Against Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa .
- Author
-
Malisova L, Vrbova I, Pomorska K, Jakubu V, and Zemlickova H
- Subjects
- Pseudomonas aeruginosa, Microbial Sensitivity Tests, beta-Lactamases genetics, beta-Lactamases metabolism, Enterobacteriaceae genetics, Enterobacteriaceae metabolism, Cefiderocol, Carbapenems pharmacology, Anti-Bacterial Agents pharmacology
- Abstract
The objective of this study was to assess the susceptibility of cefiderocol against multidrug-resistant carbapenemase-producing and nonproducing bacteria. The panel comprised 182 isolates of the order Enterobacterales , and 40 strains of Pseudomonas aeruginosa . Antimicrobial susceptibility testing has been performed using broth microdilution method according to the European Committee on Antimicrobial Susceptibility Testing recommendations. Mass spectrometry matrix-assisted laser desorption/ionization-time of flight mass spectrometry and carbapenemase-producing test were used to verify the presence of carbapenemases in clinical isolates. The genetic expression of single carbapenemases ( bla
KPC , blaOXA-48 , blaNDM , blaVIM , blaIMP , blaGES ) was determined by real-time polymerase chain reaction. Cefiderocol exhibited a good activity against the majority of strains tested in this study. Altogether, growth of 81.9% ( n = 149) strains of the order Enterobacterales and 77.5% ( n = 31) of P. aeruginosa isolates were inhibited at minimal inhibitory concentration (MIC) ≤2 mg/L. Values MIC50 /MIC90 were 0.5/8 mg/L for enterobacteria, and 1/8 mg/L for P. aeruginosa . One isolate ( Klebsiella pneumoniae ) harboring two carbapenemases ( blaOXA-48 , blaNDM ) had cefiderocol MIC 0.5 mg/L. In enterobacteria resistant to cefiderocol, blaNDM carbapenemase prevailed (43.3%, n = 29), followed by blaOXA-48 (31.3%, n = 21) and blaKPC (4.5%, n = 3). blaIMP ( n = 8) and bl aVIM ( n = 1) metallo-β-lactamases dominated in cefiderocol-resistant P. aeruginosa ( n = 9) isolates. Very good susceptibility (100%) to this drug showed blaGES -positive strains of P. aeruginosa ( n = 8) and isolates resistant to meropenem without confirmed carbapenemase gene ( n = 10). In this study, cefiderocol demonstrated potent activity against important nosocomial pathogens, therefore, therapeutic options of this drug against multidrug-resistant bacteria should be considered.- Published
- 2023
- Full Text
- View/download PDF
33. Plasmid-mediated colistin resistance among human clinical Enterobacterales isolates: national surveillance in the Czech Republic.
- Author
-
Zelendova M, Papagiannitsis CC, Sismova P, Medvecky M, Pomorska K, Palkovicova J, Nesporova K, Jakubu V, Jamborova I, Zemlickova H, and Dolejska M
- Abstract
The occurrence of colistin resistance has increased rapidly among Enterobacterales around the world. We performed a national survey of plasmid-mediated colistin resistance in human clinical isolates through a retrospective analysis of samples from 2009 to 2017 and a prospective sampling in 2018-2020. The aim of this study was to identify and characterize isolates with mcr genes from various regions of the Czech Republic using whole genome sequencing (WGS). Of all 1932 colistin-resistant isolates analyzed, 73 (3.8%) were positive for mcr genes. Most isolates carried mcr-1 (48/73) and were identified as Escherichia coli ( n = 44) and Klebsiella pneumoniae ( n = 4) of various sequence types (ST). Twenty-five isolates, including Enterobacter spp. ( n = 24) and Citrobacter freundii ( n = 1) carrying the mcr-9 gene were detected; three of them ( Enterobacter kobei ST54) co-harbored the mcr-4 and mcr-9 genes. Multi-drug resistance phenotype was a common feature of mcr isolates and 14% (10/73) isolates also co-harbored clinically important beta-lactamases, including two isolates with carbapenemases KPC-2 and OXA-48. Phylogenetic analysis of E. coli ST744, the dominant genotype in this study, with the global collection showed Czech isolates belonged to two major clades, one containing isolates from Europe, while the second composed of isolates from diverse geographical areas. The mcr-1 gene was carried by IncX4 (34/73, 47%), IncHI2/ST4 (6/73, 8%) and IncI2 (8/73, 11%) plasmid groups. Small plasmids belonging to the ColE10 group were associated with mcr-4 in three isolates, while mcr-9 was carried by IncHI2/ST1 plasmids (4/73, 5%) or the chromosome (18/73, 25%). We showed an overall low level of occurrence of mcr genes in colistin-resistant bacteria from human clinical samples in the Czech Republic., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Zelendova, Papagiannitsis, Sismova, Medvecky, Pomorska, Palkovicova, Nesporova, Jakubu, Jamborova, Zemlickova, Dolejska and Working Group for Monitoring of Antibiotic Resistance.)
- Published
- 2023
- Full Text
- View/download PDF
34. Implication of different replicons in the spread of the VIM-1-encoding integron, In110, in Enterobacterales from Czech hospitals.
- Author
-
Bitar I, Papagiannitsis CC, Kraftova L, Marchetti VM, Petinaki E, Finianos M, Chudejova K, Zemlickova H, and Hrabak J
- Abstract
Background: VIM metallo-β-lactamases are enzymes characterized by the ability to hydrolyze all β-lactams. Usually, bla
VIM -like genes are carried by class 1 integrons. In the Czech Republic, only sporadic cases of VIM-producing Enterobacterales have been reported in which those isolates carried the VIM-1 carbapenemase-encoding integron In110. However, during 2019-2020, an increased number was reported. Therefore, the aim of the current study was to characterize the genetic elements involved in the increased spread of blaVIM genes., Materials and Methods: 32 VIM-producing Enterobacterales collected between 2019 and 2020 were subjected to: antimicrobial susceptibility testing, integron analysis, and short reads sequencing. Based on the results, 19 isolates were selected as representative and sequenced using Sequel I platform., Results: The 32 VIM-producing isolates exhibited variations in the MICs of carbapenems. Based on short-read data, 26 of the 32 sequenced isolates harbored the blaVIM-1 allele while six isolates carried the blaVIM-4 gene. The most prevalent was the In110 integron ( n = 24) and two isolates carried the In4873 class 1 integron. The blaVIM-4 allele was identified in class 1 integrons In1174 ( n = 3), In416 ( n = 1), In2143 ( n = 1) and In2150. Long reads sequencing revealed that the blaVIM was carried by: pKPC-CAV1193-like ( n = 6), HI1 (pNDM-CIT; n = 4), HI2 ( n = 3), FIB (pECLA; n = 2) and N ( n = 1) incompatibility groups. Two blaVIM -carrying plasmids could not be typed by the database, while another one was integrated into the chromosome., Conclusion: We observed the spread of VIM-encoding integrons, mainly of In110, among Enterobacterales isolated from Czech hospitals, but also an increased number of novel elements underlining the ongoing evolution., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Bitar, Papagiannitsis, Kraftova, Marchetti, Petinaki, Finianos, Chudejova, Zemlickova and Hrabak.)- Published
- 2023
- Full Text
- View/download PDF
35. Characterization of Haemophilus influenzae Strains with Non-Enzymatic Resistance to β-Lactam Antibiotics Caused by Mutations in the PBP3 Gene in the Czech Republic in 2010-2018.
- Author
-
Jakubu V, Malisova L, Musilek M, Pomorska K, and Zemlickova H
- Abstract
The surveillance data on antibiotic resistance of Haemophilus influenzae have shown that strains with non-enzymatic resistance to β-lactam antibiotics have been on the rise in the Czech Republic over the last decade. This type of resistance is more difficult to detect than β-lactamase production. Analysis of 228 H. influenzae strains revealed that isolates with non-enzymatic resistance to β-lactams due to mutations in the ftsI gene could be reliably demonstrated by single run testing of susceptibility to amoxicillin/clavulanic acid (sensitivity of detection is 84.6%), cefuroxime (92.6%), ampicillin and penicillin (both 95.7%). Thirty-seven different amino acid substitution combinations were detected in the PBP3 protein at 23 positions (V329I, D350N, S357N, A368T, M377I, S385T, A388V, L389F, P393L, A437S, I449V, G490E, I491V, R501L, A502S, A502T, A502V, V511A, R517H, I519L, N526K, A530S, and T532S). The most common combination (35%) of amino acid substitutions was the combination D350N, M377I, A502V, N526K. Epidemiological typing does not indicate a clonal spread of a particular MLST type. Altogether there has been detected 74 STs. The most prevalent ST 1034 was associated mainly with a combination D350N, M377I, A502V, N526K. Clonal analysis revealed six clonal complexes (CCs) with the founder found, eight CCs without founder and 33 singletons.
- Published
- 2021
- Full Text
- View/download PDF
36. Evidence of an epidemic spread of KPC-producing Enterobacterales in Czech hospitals.
- Author
-
Kraftova L, Finianos M, Studentova V, Chudejova K, Jakubu V, Zemlickova H, Papagiannitsis CC, Bitar I, and Hrabak J
- Subjects
- Anti-Bacterial Agents pharmacology, Bacterial Proteins genetics, Czech Republic epidemiology, Epidemics, Humans, Klebsiella Infections microbiology, Klebsiella pneumoniae metabolism, Bacterial Proteins metabolism, Drug Resistance, Bacterial, Hospitals statistics & numerical data, Klebsiella Infections epidemiology, Klebsiella pneumoniae isolation & purification, beta-Lactamases metabolism
- Abstract
The aim of the present study is to describe the ongoing spread of the KPC-producing strains, which is evolving to an epidemic in Czech hospitals. During the period of 2018-2019, a total of 108 KPC-producing Enterobacterales were recovered from 20 hospitals. Analysis of long-read sequencing data revealed the presence of several types of bla
KPC -carrying plasmids; 19 out of 25 blaKPC -carrying plasmids could be assigned to R (n = 12), N (n = 5), C (n = 1) and P6 (n = 1) incompatibility (Inc) groups. Five of the remaining blaKPC -carrying plasmids were multireplicon, while one plasmid couldn't be typed. Additionally, phylogenetic analysis confirmed the spread of blaKPC -carrying plasmids among different clones of diverse Enterobacterales species. Our findings demonstrated that the increased prevalence of KPC-producing isolates was due to plasmids spreading among different species. In some districts, the local dissemination of IncR and IncN plasmids was observed. Additionally, the ongoing evolution of blaKPC -carrying plasmids, through genetic rearrangements, favours the preservation and further dissemination of these mobile genetic elements. Therefore, the situation should be monitored, and immediate infection control should be implemented in hospitals reporting KPC-producing strains., (© 2021. The Author(s).)- Published
- 2021
- Full Text
- View/download PDF
37. Antibiotic Resistance, spa Typing and Clonal Analysis of Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates from Blood of Patients Hospitalized in the Czech Republic.
- Author
-
Pomorska K, Jakubu V, Malisova L, Fridrichova M, Musilek M, and Zemlickova H
- Abstract
Staphylococcus aureus is one of the major causes of bloodstream infections. The aim of our study was to characterize methicillin-resistant Staphylococcus aureus (MRSA) isolates from blood of patients hospitalized in the Czech Republic between 2016 and 2018. All MRSA strains were tested for antibiotic susceptibility, analyzed by spa typing and clustered using a Based Upon Repeat Pattern (BURP) algorithm. The representative isolates of the four most common spa types and representative isolates of all spa clonal complexes were further typed by multilocus sequence typing (MLST) and staphylococcal cassette chromosome mec (SCC mec ) typing. The majority of MRSA strains were resistant to ciprofloxacin (94%), erythromycin (95.5%) and clindamycin (95.6%). Among the 618 strains analyzed, 52 different spa types were detected. BURP analysis divided them into six different clusters. The most common spa types were t003, t586, t014 and t002, all belonging to the CC5 (clonal complex). CC5 was the most abundant MLST CC of our study, comprising of 91.7% (n = 565) of spa- typeable isolates. Other CCs present in our study were CC398, CC22, CC8, CC45 and CC97. To our knowledge, this is the biggest nationwide study aimed at typing MRSA blood isolates from the Czech Republic.
- Published
- 2021
- Full Text
- View/download PDF
38. The association of pili with the emergence and replacement of the major antibiotic resistant pneumococcal clones.
- Author
-
Zemlickova H, Jakubu V, Fridrichova M, Malisova L, Martin Musilek, and Trojanek M
- Subjects
- Bacterial Typing Techniques, Czech Republic, Drug Resistance, Multiple, Bacterial genetics, Erythromycin, Microbial Sensitivity Tests, Multilocus Sequence Typing, Penicillin Resistance, Penicillins pharmacology, Pneumococcal Vaccines, Polymerase Chain Reaction, Prevalence, Serogroup, Streptococcus pneumoniae genetics, Streptococcus pneumoniae isolation & purification, Anti-Bacterial Agents pharmacology, Drug Resistance, Multiple, Bacterial drug effects, Streptococcus pneumoniae drug effects
- Abstract
Background: The aim of this study was to evaluate the presence of pilus islet 1 (PI-1) and to determine its clade type in pneumococcal isolates with reduced susceptibility to penicillin (penicillin non-susceptible pneumococci - PNSP) and/or resistant to macrolides isolated prior to and after the introduction of pneumococcal conjugate vaccines (PCVs) in the Czech Republic., Methods: Clinical isolates of serotypes 9V (n = 68) and 19A (n = 89) were examined. Isolates were characterised by multilocus sequence typing (MLST). The presence of PI-1 was determined by screening for the sortase B, C, and D genes located within PI-1. In the presence of PI-1 pilus, clade types were classified by PCR., Results: In the pre-PCV period (2000-2007), the prevalence of PNSP was 3.9% and 2.7% of isolates were resistant to erythromycin. During 2012-2015 (post-PCV period), the rates of PNSP remained stable (3.6%), but resistance to erythromycin increased to 8.3%. While in 2000-2007, resistance to antibiotics was associated mainly with serotype 9V, in 2012-2015, it was replaced by serotype 19A. PI-1 positive isolates were seen in both serotypes. All isolates (68) of serotype 9V belonged to the Spain
9V -3 (CC156) clone and carried PI-1 of clade type I while 96.5% (56/58) of isolates of 19A serotype belonged to the Netherlands15B -37 (CC199) clone and carried PI-1 of clade type II., Conclusions: Both major antibiotic resistant clones carried PI-1, although they differ in the clade type. Thus the role of PI-1 should be evaluated in further studies and potentially considered in the spread of antibiotic resistant clones., (Copyright © 2019. Published by Elsevier B.V.)- Published
- 2020
- Full Text
- View/download PDF
39. Insufficient repeatability and reproducibility of MALDI-TOF MS-based identification of MRSA.
- Author
-
Paskova V, Chudejova K, Sramkova A, Kraftova L, Jakubu V, Petinaki EA, Zemlickova H, Neradova K, Papagiannitsis CC, and Hrabak J
- Subjects
- Bacterial Toxins genetics, Diagnostic Errors, Diagnostic Tests, Routine, Humans, Methicillin-Resistant Staphylococcus aureus genetics, Reproducibility of Results, Sensitivity and Specificity, Staphylococcal Infections microbiology, Methicillin-Resistant Staphylococcus aureus isolation & purification, Molecular Diagnostic Techniques, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Staphylococcal Infections diagnosis
- Abstract
Rapid identification of methicillin-resistant Staphylococcus aureus (MRSA) is essential for proper initial antibiotic therapy and timely set up of hygienic measures. Recently, detection of MRSA using MALDI-TOF mass spectrometer mediated by the peptide-phenol-soluble modulin (PSM-mec)-linked to the class A mec gene complex present in SCCmec cassettes types II, III, and VIII of MRSA strains, has been commercially available. We present here a multicentre study on MALDI-TOF MS detection of MRSA evincing a poor repeatability and reproducibility of the assay. The sensitivity of the assay varies between 50 and 90% in strains carrying psm
MEC and psmδ genes encoding for PSM-mec and δ-toxin (a member of the PSM peptide family), respectively. No false positive results were found. The very major error calculation was 30% and the major error achieved 0%. Interlaboratory repeatability varies between 0 and 100%. No significant difference was observed with the use of different cultivation media. Our data showed a poor sensitivity of the method excluding it from the use in routine laboratory testing.- Published
- 2020
- Full Text
- View/download PDF
40. Whole genome sequencing of macrolide resistant Streptococcus pneumoniae serotype 19A sequence type 416.
- Author
-
Spanelova P, Jakubu V, Malisova L, Musilek M, Kozakova J, Papagiannitsis CC, Bitar I, Hrabak J, Pantosti A, Del Grosso M, and Zemlickova H
- Subjects
- Czech Republic, Genome, Bacterial, High-Throughput Nucleotide Sequencing, Humans, Italy, Multilocus Sequence Typing, Netherlands, Phylogeny, Phylogeography, Polymorphism, Single Nucleotide, Portugal, Serogroup, Streptococcus pneumoniae drug effects, Streptococcus pneumoniae genetics, Streptococcus pneumoniae isolation & purification, Drug Resistance, Bacterial, Macrolides pharmacology, Pneumococcal Infections microbiology, Streptococcus pneumoniae classification, Whole Genome Sequencing methods
- Abstract
Background: The resistance of Streptococcus pneumoniae to macrolides is becoming an increasingly important issue and thus it is important to understand the genetics related to adaptation of this species to the widespread use of antibiotics in Europe. The 58 isolates of S. pneumoniae belonging to sequence type (ST) 416 and serotype 19A and to several different phenotypes originated from Italy, Portugal and Czech Republic were thus sequenced on Illumina MiSeq. The aim of the study was to describe genetical origine of isolates, investigate their macrolide resistance and suggest reasons for spread of ST416 in the Czech Republic., Results: Investigation of genes associated with serotype determined serotype switch between 15B and 19A serotypes and core genome multilocus sequence typing (cgMLST) confirmed the origine of concerned isolates in Netherlands
15B -37 clone. Inspected genomes proved variability of genes associated with the macrolide resistance even within closely genetically relative isolates., Conclusions: Participation of 19A/ST416 on the spread of Netherlands15B -37 is accompanied by serotype switch between 19A and 15B serotypes and with acquisition of genes involved in macrolide resistance to the clone that was originally macrolide susceptible. There is evident tendency to interchanging and modifications of these and surrounding genes, that could lead to accelerate spreading of this sequence type in regions with high macrolide consumption.- Published
- 2020
- Full Text
- View/download PDF
41. Antibiotic administration reduces the rate of intraamniotic inflammation in preterm prelabor rupture of the membranes.
- Author
-
Kacerovsky M, Romero R, Stepan M, Stranik J, Maly J, Pliskova L, Bolehovska R, Palicka V, Zemlickova H, Hornychova H, Spacek J, Jacobsson B, Pacora P, and Musilova I
- Subjects
- Adult, Amniotic Fluid chemistry, Bacterial Infections etiology, Chorioamnionitis etiology, Cohort Studies, DNA, Bacterial analysis, Female, Humans, Interleukin-6 analysis, Pregnancy, Retrospective Studies, Ureaplasma genetics, Anti-Bacterial Agents therapeutic use, Bacterial Infections prevention & control, Chorioamnionitis prevention & control, Clarithromycin therapeutic use, Clindamycin therapeutic use, Fetal Membranes, Premature Rupture, Penicillin G therapeutic use
- Abstract
Background: Preterm prelabor rupture of the membranes (PPROM) is frequently complicated by intraamniotic inflammatory processes such as intraamniotic infection and sterile intraamniotic inflammation. Antibiotic therapy is recommended to patients with PPROM to prolong the interval between this complication and delivery (latency period), reduce the risk of clinical chorioamnionitis, and improve neonatal outcome. However, there is a lack of information regarding whether the administration of antibiotics can reduce the intensity of the intraamniotic inflammatory response or eradicate microorganisms in patients with PPROM., Objective: The first aim of the study was to determine whether antimicrobial agents can reduce the magnitude of the intraamniotic inflammatory response in patients with PPROM by assessing the concentrations of interleukin-6 in amniotic fluid before and after antibiotic treatment. The second aim was to determine whether treatment with intravenous clarithromycin changes the microbial load of Ureaplasma spp DNA in amniotic fluid., Study Design: A retrospective cohort study included patients who had (1) a singleton gestation, (2) PPROM between 24+0 and 33+6 weeks, (3) a transabdominal amniocentesis at the time of admission, and (4) intravenous antibiotic treatment (clarithromycin for patients with intraamniotic inflammation and benzylpenicillin/clindamycin in the cases of allergy in patients without intraamniotic inflammation) for 7 days. Follow-up amniocenteses (7
th day after admission) were performed in the subset of patients with a latency period lasting longer than 7 days. Concentrations of interleukin-6 were measured in the samples of amniotic fluid with a bedside test, and the presence of microbial invasion of the amniotic cavity was assessed with culture and molecular microbiological methods. Intraamniotic inflammation was defined as a bedside interleukin-6 concentration ≥745 pg/mL in the samples of amniotic fluid. Intraamniotic infection was defined as the presence of both microbial invasion of the amniotic cavity and intraamniotic inflammation; sterile intraamniotic inflammation was defined as the presence of intraamniotic inflammation without microbial invasion of the amniotic cavity., Results: A total of 270 patients with PPROM were included in this study: 207 patients delivered within 7 days and 63 patients delivered after 7 days of admission. Of the 63 patients who delivered after 7 days following the initial amniocentesis, 40 underwent a follow-up amniocentesis. Patients with intraamniotic infection (n = 7) and sterile intraamniotic inflammation (n = 7) were treated with intravenous clarithromycin. Patients without either microbial invasion of the amniotic cavity or intraamniotic inflammation (n = 26) were treated with benzylpenicillin or clindamycin. Treatment with clarithromycin decreased the interleukin-6 concentration in amniotic fluid at the follow-up amniocentesis compared to the initial amniocentesis in patients with intraamniotic infection (follow-up: median, 295 pg/mL, interquartile range [IQR], 72-673 vs initial: median, 2973 pg/mL, IQR, 1750-6296; P = .02) and in those with sterile intraamniotic inflammation (follow-up: median, 221 pg/mL, IQR 118-366 pg/mL vs initial: median, 1446 pg/mL, IQR, 1300-2941; P = .02). Samples of amniotic fluid with Ureaplasma spp DNA had a lower microbial load at the time of follow-up amniocentesis compared to the initial amniocentesis (follow-up: median, 1.8 × 104 copies DNA/mL, 2.9 × 104 to 6.7 × 108 vs initial: median, 4.7 × 107 copies DNA/mL, interquartile range, 2.9 × 103 to 3.6 × 107 ; P = .03)., Conclusion: Intravenous therapy with clarithromycin was associated with a reduction in the intensity of the intraamniotic inflammatory response in patients with PPROM with either intraamniotic infection or sterile intraamniotic inflammation. Moreover, treatment with clarithromycin was related to a reduction in the load of Ureaplasma spp DNA in the amniotic fluid of patients with PPROM <34 weeks of gestation., (Copyright © 2020 Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
42. Isolation of Bordetella trematum from the respiratory tract of a patient with lung cancer: a case report.
- Author
-
Kukla R, Svarc M, Bolehovska R, Ryskova L, Paterova P, Fajfr M, Malisova L, and Zemlickova H
- Subjects
- Aged, Anti-Bacterial Agents therapeutic use, Bordetella drug effects, Bordetella Infections drug therapy, Fatal Outcome, Humans, Male, RNA, Ribosomal, 16S genetics, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Bordetella isolation & purification, Bordetella Infections diagnosis, Lung Neoplasms complications, Respiratory System microbiology
- Abstract
We report the case of isolation of Bordetella trematum from the respiratory tract of a patient with lung carcinoma. This gram-negative, opportunistic rod was firstly described in 1996. To date, only several strains of Bordetella trematum have been isolated and reported, mostly from skin and soft tissue infections. The patient was admitted to the ICU of the Pulmonary Department in incipient septic shock with respiratory failure. Intravenous fluid resuscitation and non-invasive ventilation were administered immediately. A broad spectrum antibiotic piperacillin/tazobactam was administered empirically after sampling of material for microbiological examination. The bronchoscopy showed a large cavern of decayed tumour invading into mediastinum. Both sample cultures showed significant quantities of gram-negative non-fermenting bacteria. The isolate was identified using MALDI-TOF MS as Bordetella trematum and the identification was confirmed using 16S ribosomal RNA sequencing. In the last few years, routine bacterial identification using MALDI-TOF MS has enabled correct discrimination of this species. Nevertheless, isolation of Bordetella trematum in clinical samples is still very uncommon, and it is appropriate to confirm the species identification via 16S ribosomal RNA sequencing. To our knowledge, this is the first case of B. trematum isolated from the human respiratory tract since its first description. The clinical significance of Bordetella trematum in the rapid deterioration of the patient's status remains unclear.
- Published
- 2020
- Full Text
- View/download PDF
43. Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from bloodstream cultures at University Hospital in the Czech Republic.
- Author
-
Neradova K, Fridrichova M, Jakubu V, Pomorska K, and Zemlickova H
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents pharmacology, Bacteremia microbiology, Bacterial Typing Techniques, Child, Child, Preschool, Czech Republic epidemiology, Female, Genotype, Hospitals, University, Humans, Infant, Male, Methicillin-Resistant Staphylococcus aureus classification, Methicillin-Resistant Staphylococcus aureus drug effects, Microbial Sensitivity Tests, Middle Aged, Multilocus Sequence Typing, Phenotype, Young Adult, Bacteremia epidemiology, Methicillin-Resistant Staphylococcus aureus isolation & purification, Staphylococcal Infections epidemiology
- Abstract
The aim of this study was to trace the dynamic changes of methicillin-resistant Staphylococcus aureus (MRSA) lineages in the local hospital in both the national and international context. We describe genotypic and phenotypic characterization of 62 non-duplicate MRSA isolates collected during 2010-2016 at University Hospital in Hradec Kralove, Czech Republic. The isolates were characterized by multilocus sequence typing (MLST), spa typing, and staphylococcal cassette chromosome mec typing (SCCmec typing). Eight different genotypes were described; ST225-t003-II (32/62, 52%), ST5-t002-II (13/62, 22%), and ST225-t014-II (12/62, 21%) were constantly detected over the 7-year follow-up period. The genotypes ST225-t151-II, ST225-t1282-II, ST225-t1623-II, ST78-t2832-II, and ST225-t8799-II occurred only once in the period reported. The majority of the strains, represented by ST225, belonged to clonal complex 5 (CC5).
- Published
- 2020
- Full Text
- View/download PDF
44. Improved laboratory diagnostics of Streptococcus pneumoniae in respiratory tract samples through qPCR.
- Author
-
Kukla R, Bolehovska R, Radocha J, Pliskova L, Zak P, Vrbacky F, Nekvindova J, and Zemlickova H
- Subjects
- DNA, Bacterial genetics, Humans, Respiratory System microbiology, Sensitivity and Specificity, Streptococcus pneumoniae genetics, Community-Acquired Infections diagnosis, Community-Acquired Infections microbiology, Pneumonia, Pneumococcal diagnosis, Pneumonia, Pneumococcal microbiology, Real-Time Polymerase Chain Reaction
- Abstract
The aim of this study was to test the detection performance of the cpsA, lytA and ply genes through qPCR in the identification of Streptococcus pneumoniae in respiratory tract samples. Specificity was tested on a panel of 128 streptococci and other bacteria DNA samples. The qPCR assay was tested on a total of 51 respiratory tract samples from patients with community-acquired pneumonia (CAP). The specificity of the cpsA, lytA and ply genes was 100%, 100%, and 86%, respectively. The quantitative assessment, based on lytA, determined a cutoff value of ~2x104, 4x102 and 4x102 DNA copies per 1 mL of valid sputum, tracheal aspirate and bronchial aspirate samples, respectively. The results from the present study suggest that qPCR detection of all three genes would be optimal in the accurate detection of Streptococcus pneumoniae.
- Published
- 2020
45. Lactobacilli-dominated cervical microbiota in women with preterm prelabor rupture of membranes.
- Author
-
Kacerovsky M, Pliskova L, Bolehovska R, Gerychova R, Janku P, Matlak P, Simetka O, Faist T, Mls J, Vescicik P, Zemlickova H, Jacobsson B, and Musilova I
- Subjects
- Cervix Uteri microbiology, Chlamydia trachomatis, Female, Humans, Infant, Newborn, Microbiota, Mycoplasma hominis, Obstetric Labor, Premature, Pregnancy, Retrospective Studies, Ureaplasma, Amniocentesis methods, Amniotic Fluid microbiology, Chorioamnionitis microbiology, Fetal Membranes, Premature Rupture microbiology, Lactobacillus, Lactobacillus crispatus
- Abstract
Background: To determine the association between microbial invasion of the amniotic cavity (MIAC) and the presence of Lactobacillus crispatus- or Lactobacillus iners-dominated cervical microbiota in pregnancies with preterm prelabor rupture of membrane. Next, to assess the relationship between the presence of L. crispatus- or L. iners-dominated cervical microbiota and short-term neonatal morbidity., Method: A total of 311 women were included. Cervical samples were obtained using a Dacron polyester swab and amniotic fluid samples were obtained by transabdominal amniocentesis. Bacterial DNA, L. crispatus, and L. iners in the cervical samples were assessed by PCR. Cervical microbiota was assigned as L. crispatus- or L. iners-dominated when the relative abundance of L. crispatus or L. iners was ≥50% of the whole cervical microbiota, respectively., Results: Women with MIAC showed a lower rate of L. crispatus-dominated cervical microbiota (21% vs. 39%; p = 0.003) than those without MIAC. Lactobacillus crispatus-dominated cervical microbiota was associated with a lower rate of early-onset sepsis (0% vs. 5%; p = 0.02)., Conclusions: The presence of L. crispatus-dominated cervical microbiota in women with preterm prelabor rupture of membrane was associated with a lower risk of intra-amniotic complications and subsequent development of early-onset sepsis of newborns.
- Published
- 2020
- Full Text
- View/download PDF
46. Methicillin-resistant Staphylococcus aureus in veterinary professionals in 2017 in the Czech Republic.
- Author
-
Neradova K, Jakubu V, Pomorska K, and Zemlickova H
- Subjects
- Adult, Aged, Animals, Carrier State epidemiology, Carrier State microbiology, Czech Republic epidemiology, Education, Veterinary, Genotype, Humans, Methicillin-Resistant Staphylococcus aureus genetics, Middle Aged, Nose microbiology, Occupational Exposure, Prevalence, Staphylococcal Infections epidemiology, Students, Methicillin-Resistant Staphylococcus aureus classification, Methicillin-Resistant Staphylococcus aureus isolation & purification, Veterinarians
- Abstract
Background: Cases of colonization or infection caused by Methicillin-resistant Staphylococcus aureus (MRSA) are frequently reported in people who work with animals, including veterinary personnel. The aim of this study was to determine the prevalence of MRSA colonization among veterinary professionals. A total of 134 nasal swabs from healthy attendees of a veterinary conference held in the Czech Republic were tested for presence of MRSA. The stains were further genotypically and phenotypically characterized., Results: Nine isolated MRSA strains were characterized with sequence type (ST), spa type (t) and Staphylococcal Cassette Chromosome mec type. Five different genotypes were described, including ST398-t011-IV (n = 5), ST398-t2330-IV (n = 1), ST398-t034-V (n = 1), ST225-t003-II (n = 1) and ST4894-t011-IV (n = 1). The carriage of the animal MRSA strain was confirmed in 8 cases, characteristics of one strain corresponded to the possible nosocomial origin. Among animal strains were described three spa types (t011, t034, t2330) belonging into one dominating clonal complex spa-CC11., Conclusion: According to our results, the prevalence of nasal carriage of MRSA in veterinary personnel is 6.72%. Although we described an increase compared to the results of previous study (year 2008), the prevalence in the Czech Republic is still remaining lower than reported from neighboring countries. Our results also indicate that healthcare - associated MRSA strains are still not spread among animals.
- Published
- 2020
- Full Text
- View/download PDF
47. Complete Nucleotide Sequences of mcr-4.3 -Carrying Plasmids in Acinetobacter baumannii Sequence Type 345 of Human and Food Origin from the Czech Republic, the First Case in Europe.
- Author
-
Bitar I, Medvecky M, Gelbicova T, Jakubu V, Hrabak J, Zemlickova H, Karpiskova R, and Dolejska M
- Subjects
- Aged, 80 and over, Czech Republic, Drug Resistance, Bacterial genetics, Europe, Female, Humans, Microbial Sensitivity Tests, Peptides genetics, Acinetobacter baumannii genetics, Plasmids genetics
- Abstract
Here, we describe two plasmids carrying mcr-4.3 in two Acinetobacter baumannii strains isolated from imported food and a clinical sample. The comparative analysis of these plasmids, with two other plasmids reported in the NCBI database, highlighted the common origin of the plasmidic structure carrying mcr-4.3 This is the first case of the mcr-4.3 gene in a A. baumannii strain isolated from a clinical case in Europe. We hypothesize that food import is initiating the spread in Czech Republic., (Copyright © 2019 American Society for Microbiology.)
- Published
- 2019
- Full Text
- View/download PDF
48. Pentraxin 3 in Noninvasively Obtained Cervical Fluid Samples from Pregnancies Complicated by Preterm Prelabor Rupture of Membranes.
- Author
-
Janku P, Kacerovsky M, Zednikova B, Andrys C, Kolackova M, Drahosova M, Pliskova L, Zemlickova H, Gerychova R, Simetka O, Matlak P, Jacobsson B, and Musilova I
- Subjects
- Amniotic Fluid microbiology, Biomarkers metabolism, Chorioamnionitis diagnosis, Chorioamnionitis microbiology, Enzyme-Linked Immunosorbent Assay, Female, Fetal Membranes, Premature Rupture diagnosis, Fetal Membranes, Premature Rupture microbiology, Humans, Predictive Value of Tests, Pregnancy, Retrospective Studies, Up-Regulation, C-Reactive Protein metabolism, Cervix Uteri metabolism, Chorioamnionitis metabolism, Fetal Membranes, Premature Rupture metabolism, Serum Amyloid P-Component metabolism
- Abstract
Problem: To determine the changes of pentraxin 3 (PTX3) level in noninvasively obtained cervical fluid samples from women with preterm prelabor rupture of membranes (PPROM) based on the presence of microbial invasion of the amniotic cavity (MIAC) and/or intra-amniotic inflammation (IAI), and intra-amniotic infection (the presence of both MIAC and IAI)., Methods of Study: A total of 160 women with PPROM were included. Cervical fluid samples were obtained using a Dacron polyester swab and amniotic fluid samples were obtained by transabdominal amniocentesis. Cervical fluid PTX3 levels were assessed using enzyme-linked immunosorbent assay., Results: PTX3 was found in all the cervical fluid samples and its levels were higher in women with MIAC, IAI, and intra-amniotic infection than in women without these conditions. When the women were categorized into four subgroups based on the presence of MIAC and/or IAI, women with intra-amniotic infection had higher cervical fluid PTX3 levels than those with sterile IAI (IAI alone), colonization (MIAC alone), or no MIAC or IAI. A cervical fluid PTX3 level of 11 ng/mL was the best value for identifying the presence of intra-amniotic infection in women with PPROM., Conclusions: PTX3 is a constituent of cervical fluid of women with PPROM. Cervical fluid PTX3 level reflects the situation in the intra-amniotic compartments of women with PPROM. Cervical fluid PTX3 is a potential marker for the noninvasive identification of intra-amniotic infection in PPROM., (© 2019 S. Karger AG, Basel.)
- Published
- 2019
- Full Text
- View/download PDF
49. Amniotic fluid cell-free DNA in preterm prelabor rupture of membranes.
- Author
-
Kacerovsky M, Vlkova B, Musilova I, Andrys C, Pliskova L, Zemlickova H, Stranik J, Halada P, Jacobsson B, and Celec P
- Subjects
- Adult, Amniocentesis, Amniotic Fluid microbiology, Chlamydia trachomatis, Cohort Studies, Culture Techniques, Female, Gestational Age, Humans, Interleukin-6 metabolism, Mycoplasma hominis, Polymerase Chain Reaction, Pregnancy, RNA, Ribosomal, 16S analysis, Real-Time Polymerase Chain Reaction, Retrospective Studies, Ureaplasma, Amniotic Fluid metabolism, Bacterial Infections metabolism, Cell-Free Nucleic Acids metabolism, Chorioamnionitis metabolism, DNA, Mitochondrial metabolism, Fetal Membranes, Premature Rupture metabolism, Inflammation metabolism
- Abstract
Introduction: We evaluated the levels of cell-free nuclear DNA (nDNA) and cell-free mitochondrial DNA (mtDNA) in the amniotic fluid supernatant from pregnancies complicated by preterm prelabor rupture of membranes (PPROM) based on evidence of microbial invasion of the amniotic cavity (MIAC) and/or intra-amniotic inflammation (IAI)., Material and Methods: A total of 155 women with PPROM were included in this study. Amniotic fluid samples were obtained by transabdominal amniocentesis. The levels of cell-free nDNA and mtDNA in the amniotic fluid supernatant were assessed and quantified by real-time polymerase chain reaction., Results: The levels of cell-free nDNA and mtDNA were higher in women with MIAC and IAI than in women without these conditions (nDNA: with MIAC: median 3.9 × 10
4 genome equivalent [GE]/mL vs without MIAC: median 1.2 × 104 GE/mL, with IAI: median: 5.3 × 104 GE/mL vs without IAI: median 1.2 × 104 GE/mL; mtDNA: with MIAC: median 9.2 × 105 GE/mL vs without MIAC: median 2.5 × 105 GE/mL, with IAI: median 1.1 × 106 GE/mL vs without IAI: median 2.5 × 105 ; all P values ≤ 0.01). Women with the microbial-associated IAI showed the highest levels of cell-free nDNA and mtDNA., Conclusions: Cell-free nDNA and mtDNA are constituents of the amniotic fluid supernatant from PPROM pregnancies. Both cell-free nDNA and mtDNA are involved in the intra-amniotic inflammatory response in women with PPROM., (© 2018 John Wiley & Sons, Ltd.)- Published
- 2018
- Full Text
- View/download PDF
50. Cervical human papillomavirus infection in women with preterm prelabor rupture of membranes.
- Author
-
Hornychova H, Kacerovsky M, Musilova I, Pliskova L, Zemlickova H, Matejkova A, Vosmikova H, Rozkosova K, Cermakova P, Bolehovska R, Halada P, Jacobsson B, and Laco J
- Subjects
- Adult, Amniotic Fluid virology, Female, Humans, Infant, Infant Mortality, Infant, Newborn, Patient Admission, Pregnancy, Cervix Uteri virology, Fetal Membranes, Premature Rupture virology, Papillomaviridae physiology, Papillomavirus Infections complications
- Abstract
Objective: To evaluate the association between cervical human papillomavirus (HPV) infection at the time of admission and the presence of microbial invasion of the amniotic cavity (MIAC) and intra-amniotic inflammation (IAI) in women with preterm prelabor rupture of membranes (PPROM) and to determine the association between cervical HPV infection and short-term neonatal morbidity., Methods: One hundred women with singleton pregnancies complicated by PPROM between the gestational ages of 24+0 and 36+6 weeks were included in the study. The presence of HPV DNA was evaluated in scraped cervical cells using polymerase chain reaction (PCR). Amniotic fluid samples were obtained by transabdominal amniocentesis., Results: The rate of cervical HPV infection in women with PPROM was 24%. The rates of MIAC and IAI were not different between women with cervical HPV infection and those without cervical HPV infection [MIAC: with HPV: 21% (5/24) vs. without HPV: 22% (17/76), p = 1.00; IAI: with HPV: 21% (5/24) vs. without HPV: 18% (14/76), p = 0.77]. There were no differences in the selected aspects of short-term neonatal morbidity between women with and without cervical HPV infection., Conclusions: In women with PPROM, the presence of cervical HPV infection at the time of admission is not related to a higher risk of intra-amniotic infection-related and inflammatory complications or worse short-term neonatal outcomes., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.